Global Cow Colostrum Market By Type (Conventional, Organic), By Application (Nutritional Supplementation, Animal Feed, Other Applications), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031
- Published date: Jan 2022
- Report ID: 73759
- Number of Pages: 286
- Format:
- keyboard_arrow_up
The first milk produced by mammals before the birth of a new offspring is called colostrum. The colostrum has a high amount of bioactive compounds, which gives newborns immunity against various infections and diseases, as it contains antibodies that help in growth. The colostrum of cow has 100 times higher levels of antibodies than regular cow’s milk. Moreover, a special type of bovine colostrum “hyper immune bovine colostrum” has been created by researchers which are produced from cows that have been vaccinated against specific diseases.
Bovine colostrum is rich in vitamins, fats, minerals, growth hormones, carbohydrates, and digestive enzymes. The colostrum from a bovine animal is being used to develop supplements to promote immunity and to improve gut health. To produce supplements, a cow’s colostrum is dried into powder and processed into pills. Cow colostrum is light yellow and tastes like buttermilk.
The global cow colostrum market is segmented on the basis of – type, application, and region. Listed below is a detailed segmentation of this market:
By Type
- Conventional
- Organic
Application
- Nutritional Supplementation
- Animal Feed
- Other Applications
By Region
- North America
- The US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Korea
- Rest of the Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- Israel
- South Africa
- Rest of the MEA
Market Dynamics–
Growing awareness levels concerning functional foods, coupled with innovations in the food industry corresponding to the use of natural ingredients are expected to boost the revenue growth of the cow colostrum market. Furthermore, the demand for nutritional supplements, changing lifestyles, and shift of individual perspectives towards health management, in both developed and developing countries, are expected to fuel market growth prospects for this target market over the forecast period.
Unfortunately, lactose tolerance is a major concern that could affect this target market, as global research indicates that there has been an increase in overall lactose intolerant populations. However, the nutritional benefits associated with colostrum and the demand for supplements among sports-persons, coupled with the fact that products manufactured from colostrum are approved by the FDA (Food and Drug Administration) are said to lead to anticipated revenue growth opportunities for players in this market.
Competitive Landscape
Major players in this market are –
- Colostrum BioTec GmbH
- Zuche Pharmaceuticals
- Biodane Pharma A/S
- Agati Healthcare Pvt. Ltd.
- McePharma
- Cure Nutraceuticals Pvt. Ltd.
- Ingredia Nutritional (Ingredia S.A.)
- Sterling Technology
- Biotaris B.V.
- La Belle Inc.
- Now Health Group Inc.
- The Saskatoon Colostrum Company
- Good Health New Zealand
- etc
Key Developments:
- In 2021, PanTheryx, a leader in nutrition and biotechnology launched 3 product formulations comprised of bovine colostrum.
- In 2020, the Surat District Cooperative Milk Producers Union Limited developed a colostrum powder to boost immunity among patients suffering from COVID-19.
For the Cow Colostrum Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
- Colostrum BioTec GmbH
- Zuche Pharmaceuticals
- Biodane Pharma A/S
- Agati Healthcare Pvt. Ltd.
- McePharma
- Cure Nutraceuticals Pvt. Ltd.
- Ingredia Nutritional (Ingredia S.A.)
- Sterling Technology
- Biotaris B.V.
- La Belle Inc.
- Now Health Group Inc.
- The Saskatoon Colostrum Company
- Good Health New Zealand
- etc
- settingsSettings
Our Clients
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |